Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Total revenue | -18.28%9.69B | -13.99%2.75B | -40.98%2.1B | 2.23B | 2.61B | 11.85B | 3.2B | 3.55B |
Cost of revenue | -13.07%7.86B | -12.64%2.23B | -32.51%1.75B | 1.86B | 2.02B | 9.04B | 2.56B | 2.59B |
Gross profit | -35.07%1.82B | -19.50%516M | -63.62%350M | 376M | 582M | 2.81B | 641M | 962M |
Operating expense | 6.22%1.93B | 2.56%480M | 3.00%480M | 477M | 493M | 1.82B | 468M | 466M |
Operating profit | -110.69%-106M | -79.19%36M | -126.21%-130M | -101M | 89M | 992M | 173M | 496M |
Net non-operating interest income (expenses) | 0.00%41M | 0.00%-1M | 10.00%22M | 1M | 19M | 41M | -1M | 20M |
Non-operating interest income | 0.00%42M | --0 | 10.00%22M | --1M | --19M | --42M | --0 | --20M |
Non-operating interest expense | 0.00%1M | ---- | ---- | ---- | ---- | --1M | ---- | ---- |
Net investment income | 214.29%8M | 533.33%13M | 59.09%-9M | -7M | -3M | -22M | ||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 144.44%132M | 251.85%82M | -96.67%2M | 28M | 20M | 54M | -54M | 60M |
Income from associates and other participating interests | ||||||||
Special income (charges) | 64.18%-24M | 54.02%-40M | 120.00%2M | 1M | 13M | -67M | -87M | -10M |
Less:Other special charges | 83.53%-14M | 103.08%2M | -120.00%-2M | ---1M | ---13M | ---85M | ---65M | --10M |
Less:Write off | -75.00%38M | ---- | ---- | ---- | ---- | --152M | ---- | ---- |
Other non-operating income (expenses) | -76.03%29M | 10.00%11M | -70.59%10M | 2M | 6M | 121M | 10M | 34M |
Income before tax | -92.94%80M | 177.78%100M | -117.85%-103M | -65M | 148M | 1.13B | 36M | 577M |
Income tax | -100.64%-2M | -32.00%17M | -126.00%-39M | -12M | 32M | 312M | 25M | 150M |
Net income | -89.89%83M | 591.67%83M | -114.55%-62M | -54M | 116M | 821M | 12M | 426M |
Net income continuous operations | -90.01%82M | 654.55%83M | -114.99%-64M | ---53M | --116M | --821M | --11M | --427M |
Noncontrolling interests | -1M | 1M | -1M | -1M | 0 | 0 | ||
Net income attributable to the company | -90.01%82M | 608.33%85M | -115.02%-64M | -55M | 116M | 821M | 12M | 426M |
Preferred stock dividends | ||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -90.01%82M | 608.33%85M | -115.02%-64M | -55M | 116M | 821M | 12M | 426M |
Gross dividend payment | ||||||||
Basic earnings per share | -90.03%10.3 | 686.76%10.7 | -115.12%-8.1 | -6.85 | 14.55 | 103.26 | 1.36 | 53.58 |
Diluted earnings per share | -90.03%10.3 | 677.53%10.5745 | -115.12%-8.1 | -6.8989 | 14.55 | 103.26 | 1.36 | 53.58 |
Dividend per share | 0.00%15 | 0.00%7.5 | 0 | 7.5 | 0 | 15 | 7.5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |